Loading clinical trials...
Loading clinical trials...
Identifying Children With Diabetes Type 1 at High Risk for Cardiovascular Disease.
Patients with type 1 diabetes type 1 (DM1) have increased risk of death due to heart disease and stroke. These cardiovascular conditions (CVD) are the leading cause of death in patients with DM1 younger than 40 years of age and up to 35% of all persons with DM1 will die before age 55 from CVD. Strategies are needed to help identify adolescents with DM1 at risk for CVD so that interventions to prevent heart disease and stroke can be undertaken.
Patients with type 1 diabetes and healthy controls will have evaluation of their lipid profile. Arterial stiffness, heart rate variability and adiposity measurements will be done in patients with type 1 diabetes and healthy controls. Blood pressure and heart rate will be recorded. 50 ml of urine will be collected from patients and controls. All studies will be performed as a single outpatient visit at Georgetown University.
Age
12 - 21 years
Sex
ALL
Healthy Volunteers
Yes
Georgetown-Howard Universities Center
Washington D.C., District of Columbia, United States
Start Date
October 1, 2014
Primary Completion Date
October 1, 2020
Completion Date
October 1, 2020
Last Updated
April 5, 2019
240
ESTIMATED participants
Lead Sponsor
Georgetown University
Collaborators
NCT04786262
NCT06748963
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06325202